Using MRI-guided adaptive radiotherapy, investigators safely condensed prostate cancer treatment into two sessions, potentially reducing patient burden while maintaining tolerable toxicity profiles. The post Ultra-Short Radiotherapy Schedule for Prostate Cancer Supported by HERMES Trial appeared first on Inside Precision Medicine .